It is important to note that many of these technologies are still in early stages of development or clinical testing – they are not yet standard treatments, and what works for one person may not work ...
Please provide your email address to receive an email when new articles are posted on . A novel leadless conduction system pacemaker conferred stable pacing parameters at 1 month. The device dislodged ...
A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a first-in-human multicenter study. Placement of the novel UltiSynq CSP ICD ...
Jon LaPook, M.D. is the award-winning chief medical correspondent for CBS News. Since joining CBS News in 2006, LaPook has delivered more than 1,500 reports on a wide variety of breaking news and ...
There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
Amyotrophic lateral sclerosis (ALS) first garnered widespread attention in 1939, when New York Yankees baseball player Lou Gehrig was diagnosed with the neurogenerative disease. Over the decades, ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
For almost a decade, I’ve fought for a cure for a disease I don’t even have yet. In 2018, when my mom was dying of the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), I learned ...
Penn medical student, who is genetic carrier of rare form of ALS, on mission to develop gene therapy
A medical student at the University of Pennsylvania is on a special mission in the research lab that could save her life. Yentli Soto Albrecht's battle is against ALS, a fatal neurodegenerative ...
Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...
WHO 13 Meteorologist Jeriann Ritter says doctors believe she has amyotrophic lateral sclerosis, or ALS. Ritter explained how she's handling the news in a taped interview that aired on the station's 6 ...
ARE FUNDED BY BLUE CROSS BLUE SHIELD, HEALTHY BLUE FOUNDATION. 12 ON YOUR HEALTH THE PASSING OF ACTOR ERIC DANE, INCREASING AWARENESS ABOUT ALS, ALSO KNOWN AS LOU GEHRIG’S DISEASE. WXII 12 SERRA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results